People · Operator

Phillipe Chambon

Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals

1
Companies
1
Filings
$15.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Biorelix IncPharmaceuticalsSeries A$15.9M$79.2M2009
Operator network

Phillipe Chambon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Campbell Murray · 9 companies · 1 sharedCampbell MurrayDov Goldstein · 6 companies · 1 sharedDov GoldsteinJonathan M. Lourie · 3 companies · 1 sharedJonathan M. LourieRonald Lennox · 3 companies · 1 sharedRonald LennoxCampbell R. Murray · 2 companies · 1 sharedCampbell R. MurrayWilliam Wiesler · 2 companies · 1 sharedWilliam WieslerA. Donny Strosberg · 1 companies · 1 sharedA. Donny StrosbergBrian R. Dixon, Ph.D · 1 companies · 1 sharedBrian R. Dixon, P…Campbell Donny Murray · 1 companies · 1 sharedCampbell Donny Mu…Dov R. Goldstein · 1 companies · 1 sharedDov R. GoldsteinPhilipe R. Chambon · 1 companies · 1 sharedPhilipe R. ChambonPhilippe R. Chambon · 1 companies · 1 sharedPhilippe R. Chamb…Ronald R. Lennox · 1 companies · 1 sharedRonald R. LennoxWilliam R. Wiesler · 1 companies · 1 sharedWilliam R. WieslerBiorelix Inc · $15.9M raisedBiorelix IncPhillipe ChambonPC
Phillipe Chambon Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Phillipe Chambon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Campbell Murray19
Dov Goldstein16
Ronald Lennox13
Jonathan M. Lourie13
Campbell R. Murray12
William Wiesler12
Philipe R. Chambon11
Philippe R. Chambon11
Campbell Donny Murray11
A. Donny Strosberg11
Ronald R. Lennox11
Dov R. Goldstein11
Brian R. Dixon, Ph.D11
William R. Wiesler11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.